NCT05808699进行中（未招募）不适用
Camera Qualification of an Additional Fundus Camera Paired With An Autonomous AI for Detecting Diabetic Retinopathy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 626
- 试验地点
- 9
- 主要终点
- Sensitivity and Specificity Corrected for Enrichment
研究概览
简要总结
A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.
详细描述
A multi-center Study to demonstrate non-inferiority of the automated device detecting diabetic retinopathy using a handheld fundus camera with IDx-DR.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 22 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •22 years of age or older
- •Documented diagnosis of diabetes mellitus, as per any of the following:
- •Having met the criteria established by either the World Health Organization (WHO) or the American Diabetes Association (ADA)
- •Hemoglobin A1c (HbA1c) ≥ 6.5%
- •Fasting Plasma Glucose (FPG) ≥ 126 mg/dL (7.0 mmol/L)
- •Oral Glucose Tolerance Test (OGTT) with two-hour plasma glucose (2-hr PG) ≥ 200 mg/dL (11.1 mmol/L), using the equivalent of an oral 75 g anhydrous glucose dose dissolved in water
- •Symptoms of hyperglycemia or hyperglycemic crisis with a random plasma glucose (RPG) ≥ 200 mg/dL (11.1 mmol/L)
- •Ability to understand and the willingness to sign a written informed consent document
排除标准
- •Currently participating in an interventional eye study
- •Has a known allergy to or contraindication for the use of Tropicamide 1% or other mydriatic eye drops
- •Has a condition that, in the opinion of a licensed clinical team member or investigator, would preclude participation in the study (e.g., unstable medical status including blood pressure or glycemic control, microphthalmia or previous enucleation)
- •Self-report of visual symptoms including vision loss or blurred vision that cannot be corrected (e.g., with eyeglasses) or floaters
- •History of laser treatment of the retina, injections into either eye, or any history of retinal surgery
- •Previous confirmed diagnosis of a retinal disease (e.g., macular edema, severe non-proliferative retinopathy, proliferative retinopathy, radiation retinopathy, or retinal vein occlusion)
- •Any condition that is contraindicated for the use of the study camera
- •Contraindication for imaging by devices used in the study due to any of the following:
- •Subject is hypersensitive to light
- •Subject recently underwent photodynamic therapy (PDT)
- •Subject is taking medication that causes photosensitivity
结局指标
主要结局
Sensitivity and Specificity Corrected for Enrichment
时间窗: Day 1
Estimation sensitivity and specificity corrected for enrichment using logistic regression, Level 1
次要结局
- Observed Sensitivity and Specificity, Level II(Day 1)
研究者
研究点 (9)
Loading locations...
相似试验
招募中
不适用
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2Cystic Fibrosis-related DiabetesType 2 DiabetesType 1 DiabetesNCT05463289Johns Hopkins University500
撤回
不适用
Study to Compare a Fast Gama Camera for Nuclear Imaging to Conventional CameraDetect Pathalogical LesionsNCT00979355Spectrum Dynamics
尚未招募
Unknown
Role of Artificial Intelligence for Glaucoma screening in patients visiting a general ophthalmology clinicCTRI/2024/06/069657Remidio Innovative Solutions Inc
撤回
1 期
Diagnostic Aids for Detection and Diagnosis of Oral CancerHead and Neck CancerNCT02251639M.D. Anderson Cancer Center
已完成
1 期
Diabetic Foot Ulcer Prevention SystemDiabetic FootNCT02317835King's College Hospital NHS Trust105